Difficulty: Medium
Average Score: 75%
Practice
A 55-year-old patient with severe post-hepatitis cirrhosis is started on a diuretic for another condition. Two days later he is found in a coma. The drug most likely to cause coma in a patient with cirrhosis is
Correct answer
D
Rationale
The correct answer is D) Hydrochlorothiazide. In a patient with severe post-hepatitis cirrhosis, the liver's ability to metabolize drugs is compromised. Hydrochlorothiazide is a sulfonamide diuretic that can accumulate in the system due to impaired liver function, leading to increased levels of the drug in the body. This can result in adverse effects such as central nervous system toxicity, which can manifest as coma in severe cases.
Regarding the other options:
A) Acetazolamide is a carbonic anhydrase inhibitor diuretic that is less likely to cause coma in a patient with cirrhosis compared to hydrochlorothiazide.
B) Amiloride is a potassium-sparing diuretic and is not typically associated with causing coma in cirrhotic patients.
C) Furosemide, while a loop diuretic like hydrochlorothiazide, is less likely to accumulate in the system in cirrhotic patients and cause coma compared to hydrochlorothiazide.
Educationally, understanding the pharmacokinetics and pharmacodynamics of diuretics in patients with liver cirrhosis is crucial for healthcare professionals to avoid adverse drug reactions. This case highlights the importance of considering a patient's underlying conditions when prescribing medications to prevent harmful drug interactions and side effects.
Regarding the other options:
A) Acetazolamide is a carbonic anhydrase inhibitor diuretic that is less likely to cause coma in a patient with cirrhosis compared to hydrochlorothiazide.
B) Amiloride is a potassium-sparing diuretic and is not typically associated with causing coma in cirrhotic patients.
C) Furosemide, while a loop diuretic like hydrochlorothiazide, is less likely to accumulate in the system in cirrhotic patients and cause coma compared to hydrochlorothiazide.
Educationally, understanding the pharmacokinetics and pharmacodynamics of diuretics in patients with liver cirrhosis is crucial for healthcare professionals to avoid adverse drug reactions. This case highlights the importance of considering a patient's underlying conditions when prescribing medications to prevent harmful drug interactions and side effects.